| Autumn Woods Health Campus | |
| 2911 Green Valley Rd, New Albany, Indiana 47150 | |
| (812) 941-9893 | |
| Name | Autumn Woods Health Campus |
|---|---|
| Location | 2911 Green Valley Rd, New Albany, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 93 |
| Occupancy Rate | 68.06% |
| Medicare ID (CCN) | 155681 |
| Legal Business Name | Daviess County Hospital |
| Ownership Type | Government - County |
| NPI Number | 1972611036 |
| Organization Name | DAVIESS COUNTY HOSPITAL |
| Doing Business As | AUTUMN WOODS HEALTH CAMPUS |
| Address | 2911 Green Valley Rd, New Albany, IN 47150 |
| Phone Number | 812-941-9893 |
News Archive
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia. The most recent Safety Monitoring Committee meeting of April 30, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 indicated no significant safety concerns for the trials to date.
Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents. While anecdotal reports of pediatric patients with lung cancer lesions exist, little research has been conducted to link the disease in children to similar pulmonary malignancies in adults.
Steinberg Diagnostic Medical Imaging Center (SDMI) in Las Vegas needed an MR system to perform a range of patient exams at a high-volume imaging center. To solve this issue, it recently installed the first Vantage Titan 3T in the U.S. from Toshiba America Medical Systems, Inc.
Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute's Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond. Using mass spectrometry, an analytical instrument for sensitive detection and accurate
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia. The most recent Safety Monitoring Committee meeting of April 30, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 indicated no significant safety concerns for the trials to date.
Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents. While anecdotal reports of pediatric patients with lung cancer lesions exist, little research has been conducted to link the disease in children to similar pulmonary malignancies in adults.
Steinberg Diagnostic Medical Imaging Center (SDMI) in Las Vegas needed an MR system to perform a range of patient exams at a high-volume imaging center. To solve this issue, it recently installed the first Vantage Titan 3T in the U.S. from Toshiba America Medical Systems, Inc.
Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute's Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond. Using mass spectrometry, an analytical instrument for sensitive detection and accurate
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25.75 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.28 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.38 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.34 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.88 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 19.18 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.31 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20.69 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.33 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.33 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 19.91 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 23.95 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.22 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.4 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 59.78 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 68.2 | 82.93 |
News Archive
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia. The most recent Safety Monitoring Committee meeting of April 30, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 indicated no significant safety concerns for the trials to date.
Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents. While anecdotal reports of pediatric patients with lung cancer lesions exist, little research has been conducted to link the disease in children to similar pulmonary malignancies in adults.
Steinberg Diagnostic Medical Imaging Center (SDMI) in Las Vegas needed an MR system to perform a range of patient exams at a high-volume imaging center. To solve this issue, it recently installed the first Vantage Titan 3T in the U.S. from Toshiba America Medical Systems, Inc.
Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute's Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond. Using mass spectrometry, an analytical instrument for sensitive detection and accurate
› Verified 2 days ago
Green Valley Care Center Location: 3118 Green Valley Rd, New Albany, Indiana 47150 Phone: (812) 945-2341 | |
Rolling Hills Healthcare Center Location: 3625 St Joseph Rd, New Albany, Indiana 47150 Phone: (812) 948-0670 | |
Lincoln Hills Of New Albany Location: 326 Country Club Drive, New Albany, Indiana 47150 Phone: (812) 948-1311 | |
New Albany Nursing And Rehabilitation Center Location: 201 E Elm St, New Albany, Indiana 47150 Phone: (812) 945-9517 | |
Diversicare Of Providence Location: 4915 Charlestown Rd, New Albany, Indiana 47150 Phone: (812) 945-5221 | |
Autumn Woods Health Campus Location: 2911 Green Valley Rd, New Albany, Indiana 47150 Phone: (812) 941-9893 |